ThromboGenics and Geymonat Announce Euro 2 Million EU Grant for VASOPLUS Pro-Angiogenesis
17-Jan-2007 -
ThromboGenics NV and Geymonat SpA announced that the European Union has approved a Euro 2 million grant to the VASOPLUS consortium, a development programme for a new class of pro-angiogenesis agents. The funded research for VASOPLUS will be conducted within a consortium that will comprise ...
angiogenesis
Belgium
cardiology
+8